SCHEMBL18846863

SCHEMBL18846863

c1ccc(-c2nc3ccccc3c3ccc4c5ccccc5n(-c5cccc(-c6cc(-n7c8ccccc8c8ccccc87)cc(-n7c8ccccc8c8ccccc87)c6)c5)c4c23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ PDE10A Q9Y233 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.34
▸ MAPT P10636 3/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ POLB P06746 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HPGD P15428 2/20 0.33
▸ TSHR P16473 1/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ RXFP1 Q9HBX9 2/20 0.31
▸ HTT P42858 1/20 0.31
▸ DHODH Q02127 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18846598 0.96 KDM4E (0.41) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846523 0.94 L3MBTL1 (0.40) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846426 0.93 L3MBTL1 (0.41) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846712 0.92 L3MBTL1 (0.40) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846872 0.92 L3MBTL1 (0.40) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846524 0.92 L3MBTL1 (0.42) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846559 0.92 L3MBTL1 (0.42) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846869 0.92 GAA (0.39) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846723 0.92 L3MBTL1 (0.41) GAAMEN1KMT2AKDM4EL3MBTL1
SCHEMBL18846682 0.91 GAA (0.37) GAAMEN1KMT2AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 GAA 2601/4885MEN1 1034/4885KMT2A 579/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 GAA 2601/4885MEN1 1034/4885KMT2A 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback